Clonidine maintenance prolongs opioid abstinence and decouples stress from craving in daily life: A randomized controlled trial with ecological momentary assessment

American Journal of Psychiatry

Volumn 172, Issue 8, 2015, Pages 760-767

  Kowalczyk, William J ^a   Phillips, Karran A ^a   Jobes, Michelle L ^a   Kennedy, Ashley P ^a   Ghitza, Udi E ^a   Agage, Daniel A ^a   Schmittner, John P ^a   Epstein, David H ^a   Preston, Kenzie L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CLONIDINE; PLACEBO; ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADJUVANT THERAPY; ADULT; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOTENSION; HYPOVOLEMIA; INTENTION TO TREAT ANALYSIS; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEDATION; UNSPECIFIED SIDE EFFECT; URINALYSIS; WITHDRAWAL SYNDROME; XEROSTOMIA; DRUG COMBINATION; MAINTENANCE CHEMOTHERAPY; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROPORTIONAL HAZARDS MODEL; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

ADULT; ANALGESICS; BUPRENORPHINE; CLONIDINE; CRAVING; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MAINTENANCE CHEMOTHERAPY; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROPORTIONAL HAZARDS MODELS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 84938694733     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.14081014     Document Type: Article

References (40)

1. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Substance Use Disorders, 2nd ed. Am J Psychiatry 2006; 163(Aug suppl)
2. Bickel WK, Amass L, Higgins ST, et al: Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J Consult Clin Psychol 1997; 65:803-810
3. Kosten T, Oliveto A, Feingold A, et al: Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend 2003; 70:315-325
4. SilvermanK,Wong CJ, Umbricht-Schneiter A, et al: Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol 1998; 66:811-824
5. Epstein DH, Willner-Reid J, Vahabzadeh M, et al: Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry 2009; 66: 88-94
6. Marlatt GA, Gordon JRE: Relapse Prevention: Maintenance Strategies intheTreatmentofAddictiveBehaviors. NewYork,Guilford, 1985
7. Shaham Y, Shalev U, Lu L, et al: The reinstatement model of drug relapse: history, methodology, and major findings. Psychopharmacology (Berl) 2003; 168:3-20
8. BossertJM, Marchant NJ, Calu DJ, et al:The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 2013; 229:453-476
9. Erb S, Hitchcott PK, Rajabi H, et al: Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 2000; 23:138-150
10. ShahamY,Highfield D, Delfs J, et al: Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 2000; 12: 292-302
11. Highfield D, Yap J, Grimm JW, et al: Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology 2001; 25:320-331
12. Yamada H, Bruijnzeel AW: Stimulation of a2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats. Neuropharmacology 2011; 60:303-311
13. Lê AD, Harding S, Juzytsch W, et al: Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl) 2005; 179: 366-373
14. Smith RJ, Aston-Jones G: a(2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. Biol Psychiatry 2011; 70:712-719
15. Jobes ML, Ghitza UE, Epstein DH, et al: Clonidine blocks stressinduced craving in cocaine users. Psychopharmacology (Berl) 2011; 218:83-88
16. Fox HC, Seo D, Tuit K, et al: Guanfacine effects on stress, drug craving, and prefrontal activation in cocaine dependent individuals: preliminary findings. J Psychopharmacol 2012; 26:958-972
17. Fox H, Sinha R: The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. Adv Pharmacol 2014; 69:217-265
18. Sinha R, Kimmerling A, Doebrick C, et al: Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology (Berl) 2007; 190:569-574
19. Sinha R, ShahamY, HeiligM:Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) 2011; 218:69-82
20. Haney M, Hart CL, Vosburg SK, et al: Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) 2008; 197:157-168
21. Sorge RE, Rajabi H, Stewart J: Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacology 2005; 30:1681-1692
22. Leri F, Tremblay A, Sorge RE, et al: Methadonemaintenance reduces heroin-and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology 2004; 29:1312-1320
23. Gossop M: Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend 1988; 21:253-259
24. Gold MS, Redmond DE Jr, Kleber HD: Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry 1979; 136:100-102
25. Shalev U, Grimm JW, Shaham Y: Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 2002; 54:1-42
26. KalivasPW,VolkowND:Theneural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162:1403-1413
27. Shiffman S, Gwaltney CJ, Balabanis MH, et al: Immediate antecedents of cigarette smoking: an analysis from ecological momentary assessment. J Abnorm Psychol 2002; 111:531-545
28. Shiffman S, Hufford M, Hickcox M, et al: Remember that? A comparison of real-time versus retrospective recall of smoking lapses. J Consult Clin Psychol 1997; 65:292-300
29. SchwarzN: Retrospective and concurrent self-reports:Therationale for real-time data capture, in The Science of Real-Time Data Capture: Self-Reports in Health Research. Edited by Stone AA, Shiffman S, Atienza AA, et al. New York, Oxford University Press, 2007, pp 11-28
30. McLellan AT, Luborsky L, Cacciola J, et al: New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis 1985; 173:412-423
31. Robins LN, Cottler LB: Making a structured psychiatric diagnostic interview faithful to the nomenclature. Am J Epidemiol 2004; 160: 808-813
32. Lachin JM, Foulkes MA: Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986; 42:507-519
33. Higgins ST, Badger GJ, Budney AJ: Initial abstinence and success in achieving longer termcocaine abstinence. ExpClin Psychopharmacol 2000; 8:377-386
34. Bart G: Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis 2012; 31:207-225
35. Sigmon SC, Bisaga A, Nunes EV, et al: Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. Am J Drug Alcohol Abuse 2012; 38:187-199
36. Ferguson SG, Shiffman S: Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes. Psychopharmacology (Berl) 2014; 231:2595-2602
37. Ferguson SG, Shiffman S: Effect of high-dose nicotine patch on the characteristics of lapse episodes. Health Psychol 2010; 29:358-366
38. Shiffman S, Ferguson SG: The effect of a nicotine patch on cigarette craving over the course of the day: results from two randomized clinical trials. Curr Med Res Opin 2008; 24:2795-2804
39. ShiffmanS, Ferguson SG, Gwaltney CJ: Immediatehedonicresponse to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology (Berl) 2006; 184:608-618
40. Kreek MJ, Schlussman SD, Reed B, et al: Bidirectional translational research: progress inunderstandingaddictivediseases. Neuropharmacology 2009; 56(suppl 1):32-43